People · Operator
Named in public records as an officer, director or promoter · active 2008–2008 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Avalon Pharmaceuticals Inc | — | Pharmaceuticals | Pre-Seed | $237K | $11.2M | 2008 |
Stephen K. Horrigan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen K. Horrigan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| C Eric Winzer | 1 | 4 |
| Kenneth C Carter | 1 | 4 |
| William H. Washecka | 1 | 2 |
| Bradley G. Lorimier | 1 | 2 |
| David S. Kabakoff | 1 | 2 |
| J. Michael Hamilton | 1 | 1 |
| Philip Frost | 1 | 1 |
| Michael R. Kurman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.